Related Experiment Video
Updated: Aug 9, 2025

Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
Cardiometabolic Risk and Its Relationship With Visceral Adiposity in Children With Cerebral Palsy
Trevor Batson1, Junsoo Lee1, Joseph M Kindler2
1Department of Kinesiology, University of Georgia, Athens, GA 30602, USA.
Insights
Children with cerebral palsy (CP) show early cardiometabolic disease signs, including higher cholesterol and prediabetes. Increased visceral fat, not reduced physical activity, is the primary driver of these risks in pediatric CP.
Area of Science:
- Pediatric Cardiology
- Metabolic Health
- Neurology
Background:
- Adults with cerebral palsy (CP) have a higher prevalence of cardiometabolic disease.
- Research on cardiometabolic disease risk in children with CP is limited.
Purpose of the Study:
- To determine if children with CP exhibit higher cardiometabolic risk than typically developing children.
- To examine the relationship between cardiometabolic risk, visceral adiposity, and physical activity in children with CP.
Main Methods:
- Compared 30 ambulatory children with CP to 30 typically developing controls.
- Assessed blood lipids, glucose, HOMA-IR, visceral fat (VFMI), and physical activity (accelerometers).
Main Results:
- Children with CP had higher cholesterol, glucose, dyslipidemia, prediabetes, and VFMI, with lower physical activity than controls.
- Non-HDL-C and glucose correlated with VFMI; Non-HDL-C and HOMA-IR correlated with physical activity.
- HOMA-IR strongly correlated with VFMI in children with CP.
Conclusions:
- Children with CP show early cardiometabolic disease markers.
- Increased visceral adiposity is more strongly linked to cardiometabolic risk than reduced physical activity in pediatric CP.
Context:
Adults with cerebral palsy (CP) display a higher prevalence of cardiometabolic disease compared with the general population. Studies examining cardiometabolic disease risk in children with CP are limited.
Objective:
The purpose of this study was to determine if children with CP exhibit higher cardiometabolic risk than typically developing children, and to examine its relationship with visceral adiposity and physical activity.
Methods:
Thirty ambulatory children with CP and 30 age-, sex-, and race-matched typically developing control children were tested for blood lipids, glucose, and the homeostatic model assessment of insulin resistance (HOMA-IR). Visceral fat was assessed using dual-energy x-ray absorptiometry. Physical activity was assessed using accelerometer-based monitors.
Results:
Children with CP had higher total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol (non-HDL-C), glucose, prevalence of dyslipidemia, prevalence of prediabetes, and visceral fat mass index (VFMI) and lower physical activity than controls (all P < .05). In the groups combined, non-HDL-C and glucose were positively related to VFMI (r = 0.337 and 0.313, respectively, P < .05), and non-HDL-C and HOMA-IR were negatively related to physical activity (r = -0.411 and -0.368, respectively, P < .05). HOMA-IR was positively related to VFMI in children with CP (r = 0.698, P < .05), but not in controls. Glucose was not related to physical activity in children with CP, but it was negatively related in controls (r = -0.454, P < .05).
Conclusion:
Children with CP demonstrate early signs of cardiometabolic disease, which are more closely related to increased visceral adiposity than decreased physical activity.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease I: Introduction
Obesity
Cardiomyopathy IV: Restrictive Cardiomyopathy
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

